Lexaria’s Groundbreaking Research into DehydraTECH-CBD Published in International Journal of Molecular Science – Medical Marijuana Program Connection
DehydraTECH-CBD now featured in eight published, peer-reviewed papers KELOWNA, BC / ACCESSWIRE / June 22, 2023 / Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW) (the “Company” or “Lexaria”), a global innovator…
Read more Lexaria’s Groundbreaking Research into DehydraTECH-CBD Published in International Journal of Molecular Science – Medical Marijuana Program Connection